Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Inventory Average (2021 - 2025)

Cytek Biosciences (CTKB) has disclosed Inventory Average for 3 consecutive years, with $50.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average changed N/A year-over-year to $50.6 million, compared with a TTM value of $50.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $52.4 million, down 3.91% over the prior year.
  • Inventory Average was $50.6 million for Q3 2025 at Cytek Biosciences, down from $63.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $63.9 million in Q4 2023 and bottomed at $47.4 million in Q3 2022.
  • Average Inventory Average over 3 years is $52.6 million, with a median of $49.7 million recorded in 2022.
  • Peak annual rise in Inventory Average hit 31.0% in 2023, while the deepest fall reached 31.0% in 2023.
  • Year by year, Inventory Average stood at $48.8 million in 2022, then soared by 31.0% to $63.9 million in 2023, then dropped by 20.83% to $50.6 million in 2025.
  • Business Quant data shows Inventory Average for CTKB at $50.6 million in Q3 2025, $63.9 million in Q4 2023, and $48.8 million in Q4 2022.